Science Hub · Evidence & Mechanism

The Science Behind
BHW Silicol®gel

BHW Silicol®gel is not just a consumer wellness product; it is a clinically studied, MDR-compliant medical device. Explore the evidence, understand the mechanism, and discover the role of the gut microbiome in digestive health.

MDR
Compliant medical device
2×
Independent clinical trials
0 %
Clinically meaningful improvement
323→160
IBS Severity Score shift

Not just wellness — a clinically studied, MDR-compliant medical device, built on the science of colloidal silicic acid.

Colloidal silicic acid
Class IIa medical device
Evidence-led gastrointestinal care
01
Clinical Evidence

Clinically Proven
Results

Independent clinical studies have demonstrated the effectiveness and safety of BHW Silicol®gel in reducing digestive symptoms and improving quality of life.

01
Double-blind · Placebo-controlled
Study 01 — Randomised, double-blind, placebo-controlled

Efficacy in IBS-D & IBS-M Adults

Gastroenterology Research & Practice · Crawford, Taylor, Young & Hatton, 2023
0 %

of participants achieved clinically meaningful improvement.

Mean IBS Severity Score
IBS-SSS
Baseline
323 Severe
Week 4
160 Mild
−163 points
p<0.001 — highly statistically significant
Quality of life
4-week course

Quality of life scores improved consistently over 4 weeks.

02
Independent · Glasgow CPS Research
Study 02 — Independent confirmatory trial

Glasgow CPS
Independent Trial

Gastroenterology Research & Practice · CPS Research Glasgow, 2023
0 %

meaningful improvement — independently confirmed

a.

Fewer bowel motions per day, reduced urgency, improved symptom control.

b.

Well tolerated with only mild, expected effects.

c.

Published in Gastroenterology Research & Practice, CPS Research Glasgow, 2023.

02
Mechanism of Action

How Colloidal
Silicic Acid Works

BHW Silicol®gel contains colloidal silicic acid, a natural compound of silicon and oxygen in a hydrated form. Silicon is the second most abundant element on Earth and is found naturally as silicon dioxide.

protective gel layerirritants boundacid & gas adsorbedpassed naturally
Step 01

Protective Barrier

The gel forms a protective and soothing physical barrier along the mucosal lining of the stomach and intestines.

Step 02

Binds Irritants

Due to its high surface area and charge, the silica particles attract and bind irritants, bacteria, toxins, and pathogens — adsorption, not absorption.

Step 03

Relieves Acid & Gas

Excess gastric acid and gases are also adsorbed, relieving the pressure and pain of bloating and reflux.

Step 04

Naturally Expelled

As the gastrointestinal tract empties, all bound material is safely expelled — the silica is not absorbed by the body.

Over 1 in 10 people worldwide live with IBS. Many go undiagnosed for years. Silicol®gel offers a non-pharmacological, clinically backed option.

balance
disruption
restoration
03
The Gut Microbiome

Your Gut Microbiome
& Digestive Health

The gut microbiome — the trillions of bacteria living in your digestive tract — plays a central role in immune function, mood, metabolism, and overall wellness.

When disrupted by toxins, pathogens, or poor diet, it can trigger IBS, bloating, diarrhoea, and more.

01

Selective by nature.

Adsorbs harmful bacteria and toxins while leaving beneficial flora intact.

02

Non-pharmacological.

A physical, clinically backed option — can be taken with a 1-hour gap around medicines.

03

Gentle daily use.

Recommended 4-week course, 4–7 day break, then repeat as needed.

04
Evidence & Results

The Evidence,
Visualised

Two independent trials. One consistent story — meaningful relief, fast.

0
%

of participants achieved clinically meaningful improvement — reported in both independent studies

Study 01 — Results

Efficacy in IBS-D & IBS-M Adults

Gastroenterology Research & Practice · Crawford, Taylor, Young & Hatton, 2023
Mean IBS Severity Score
323 → 160
323Severe
160Mild
0
100
200
300
400
163-Point Reduction

Mean IBS Severity Score dropped from 323 (Severe) to 160 (Mild) (p<0.001).

Treatment timeline
relief often felt in week 1

Significant improvements in diarrhoea, abdominal pain, bloating and flatulence — quality of life improving consistently over 4 weeks.

Diarrhoea
Abdominal pain
Bloating
Flatulence
Study 02 — Results

Glasgow CPS Independent Trial

Gastroenterology Research & Practice · CPS Research Glasgow, 2023
0 %

meaningful improvement confirmed.

0 Weeks

of treatment with measurable symptom improvement.

Early Relief

Improvements in key IBS symptoms were observed from weeks 1–2.

Well Tolerated

Only mild, expected gastrointestinal effects were reported.

Shopping Cart
Scroll to Top